SQ109 free base · Synonyms: SQ-109 · SQ 109
SQ109 is a potent inhibitor of the trypomastigote form of the parasite.
For research use only. Not for human or veterinary use.
Research area
Infection
Purity >98%
Stock Inquire
SQ109 structure
CAS No.: 502487-67-4
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 100 mg | USD 780.00 | BP-02127-100mg | In stock | Get quote |
| 250 mg | USD 1,520.00 | BP-02127-250mg | In stock | Get quote |
| 500 mg | USD 2,400.00 | BP-02127-500mg | In stock | Get quote |
| 1 g | USD 3,800.00 | BP-02127-1g | In stock | Get quote |
Need another size or custom synthesis? Request a quote.
Description
SQ109 is a potent inhibitor of the trypomastigote form of the parasite, with IC50 for cell killing of 50±8 nM. SQ109, targets MmpL3, is an antitubercular agent.
Identifiers
- SMILES
-
C\C(C)=C/CC\C(C)=C\CNCCNC1C2CC3CC(C2)CC1C3 - InChIKey
-
JFIBVDBTCDTBRH-REZTVBANSA-N
Specifications
- MW (average)
- 330.5505
- Formula
- C22H38N2
- CAS No.
- 502487-67-4
- Physical state
- Solid
- Color
- Light yellow to yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃ 3 years; 4℃ 2 years; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO
Documents
References
[1]. Veiga-Santos P, et al. SQ109, a new drug lead for Chagas disease. Antimicrob Agents Chemother. 2015 Apr;59(4):1950-61.
[2]. Jia L, et al. Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug. Br J Pharmacol. 2005 Jan;144(1):80-7
[3]. Jia L, et al. Interspecies pharmacokinetics and in vitro metabolism of SQ109. Br J Pharmacol. 2006 Mar;147(5):476-85.